Dr. Ivan Gentile
My Social Links

Dr. Ivan Gentile

Assistant Professor
Department of Clinical Medicine and Surgery, University of Naples Federico II, Italy

Highest Degree
M.D. in Medicine from University of Naples Federico II, Italy

Share this Profile

Biography

Dr. Ivan Gentile is currently working as Assistant Professor of Infectious Diseases at University of Naples Federico II. He obtained his M.D. in Medicine from same University. His main area of interest related to Infectious Diseases. His area of expertise includes Virus-Host Interaction, Virus-Indiced Autoimmune/Disreactive Disorders, Chronic Viral Hepatitis, HBV, and HCV. He has published 33 research articles in journals contributed as author/co-author.

Area of Interest:

Biomedical Sciences
100%
Infectious Diseases
62%
Virus-Host Interaction
90%
Chronic Viral Hepatitis
75%
Disreactive Disorders
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
183
Abstracts
1

Selected Publications

  1. Morisco, F., R. Granata, T. Stroffolini, M. Guarino and L. Donnarumma et al., 2013. Sustained virological response: A milestone in the treatment of chronic hepatitis C. World J. Gastroenterol., 19: 2793-2798.
    CrossRef  |  PubMed  |  Direct Link  |  
  2. Gentile, I., L. Altieri, C. Lintas, R. Sacco and P. Curatolo et al., 2013. Urinary polyomavirus infections in neurodevelopmental disorders. Open J. Psychiatry, 3: 18-25.
    CrossRef  |  Direct Link  |  
  3. Gentile, I., G. Di Flumeri, S. Scarica, A. Frangiosa, M. Foggia, L. Reynaud and G. Borgia, 2013. Acute hepatitis C in patients undergoing hemodialysis: Experience with high-dose interferon therapy. Minerva Urol. Nefrol., 65: 83-84.
    PubMed  |  Direct Link  |  
  4. Gentile, I., G. Bonadies, A.R. Buonomo, G. Minei and F. Borrelli et al., 2013. Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient. Platelets, 24: 574-577.
    CrossRef  |  PubMed  |  Direct Link  |  
  5. Gentile, I., F. Borgia, A.R. Buonomo, G. Castaldo and G. Borgia, 2013. A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvir. Curr. Med. Chem., 20: 3733-3742.
    CrossRef  |  PubMed  |  
  6. Gentile, I., E. Zappulo, R. Militerni, A. Pascotto, G. Borgia and C. Bravaccio, 2013. Etiopathogenesis of autism spectrum disorders: Fitting the pieces of the puzzle together. Med. Hypoth., 81: 26-35.
    CrossRef  |  PubMed  |  Direct Link  |  
  7. Gentile, I., C. Bravaccio, R. Bonavolta, E. Zappulo and S. Scarica et al., 2013. Response to measles-mumps-rubella vaccine in children with autism spectrum disorders. In vivo, 27: 377-382.
    PubMed  |  Direct Link  |  
  8. Gentile, I., A. De Stefano, G. Di Flumeri, A.R. Buonomo and C. Carlomagno et al., 2013. Concomitant Interferon-alpha and chemotherapy in hepatitis C and colorectal cancer: A case report. In vivo., 27: 527-529.
    PubMed  |  Direct Link  |  
  9. Borgia, G., M.A. Carleo, G.B. Gaeta and I. Gentile, 2012. Hepatitis B in pregnancy. World J. Gastroenterol., 18: 4677-4683.
    CrossRef  |  Direct Link  |  
  10. Nardiello, S., A. Orsini, I. Gentile and G.B. Gaeta, 2011. HBV and pregnancy. Infez Med., 19: 139-146.
    PubMed  |  Direct Link  |  
  11. Leone, S., S. Borre, A.D. Monforte, G. Mordente and N. Petrosillo et al., 2010. Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections. Int. J. Infect. Dis., 4: S67-S77.
    CrossRef  |  PubMed  |  Direct Link  |  
  12. Gentile, I., M.A. Carleo, F. Borgia, G. Castaldo and G. Borgia, 2010. The efficacy and safety of telaprevir-a new protease inhibitor against hepatitis C virus. Expert Opin. Investig. Drugs, 19: 151-159.
    CrossRef  |  PubMed  |  Direct Link  |  
  13. Gentile, I., M. Talamo and G. Borgia, 2010. Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review. BMC Infect. Dis., Vol. 10. 10.1186/1471-2334-10-49.
    CrossRef  |  PubMed  |  Direct Link  |  
  14. Gentile, I. and G. Borgia, 2010. Surrogate endpoints and non-inferiority trials in chronic viral hepatitis. J. Hepatol., 52: 778-778.
    CrossRef  |  PubMed  |  Direct Link  |  
  15. Gentile, I. and G. Borgia, 2010. Development and progression of gastroesophageal varices in patients with chronic hepatitis C. Expert Rev. Anti. Infect. Ther., 8: 867-870.
    CrossRef  |  PubMed  |  Direct Link  |  
  16. Gentile, I. and D. Thabut, 2010. Noninvasive prediction of oesophageal varices: As simple as blood count? Liver Int., 30: 1091-1093.
    CrossRef  |  PubMed  |  Direct Link  |  
  17. Gentile, I., C. Viola, M. Graf, R. Liuzzi and M. Quarto et al., 2009. A simple noninvasive score predicts gastroesophageal varices in patients with chronic viral hepatitis. J. Clin. Gastroenterol, 43: 81-87.
    CrossRef  |  PubMed  |  Direct Link  |  
  18. Gentile, I., C. Viola, L. Paesano, M. D'Onofrio and E.D. Agostino et al., 2009. Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial. J. Clin. Apher., 24: 190-196.
    CrossRef  |  PubMed  |  Direct Link  |  
  19. Gentile, I., C. Viola, F. Borgia, G. Castaldo and G. Borgia, 2009. Telaprevir: A promising protease inhibitor for the treatment of hepatitis C virus infection. Curr. Med. Chem., 16: 1115-1121.
    CrossRef  |  PubMed  |  
  20. Borgia, G., I. Gentile, G. Fortunato, F. Borrelli and S. Borelli et al., 2009. Homocysteine levels and sustained virological response to pegylated-interferon α2b plus ribavirin therapy for chronic hepatitis C: A prospective study. Liver Int., 29: 248-252.
    CrossRef  |  PubMed  |  Direct Link  |  
  21. Fortunato, G., G. Calcagno, V. Bresciamorra, E. Salvatore and A. Filla et al., 2008. Multiple sclerosis and hepatitis C virus infection are associated with single nucleotide polymorphisms in interferon pathway genes. J. Interf. Cytokine Res., 28: 141-152.
    CrossRef  |  PubMed  |  Direct Link  |  
  22. Tosone, G., G. Borgia, I. Gentile, R. Cerini, M.C. Conte, R. Orlando and M. Piazza, 2007. A case of pegylated interferon alpha-related diabetic ketoacidosis: Can this complication be avoided? Acta Diabetol, 44: 167-169.
    CrossRef  |  PubMed  |  Direct Link  |  
  23. Reynaud, L., M. Graf, I. Gentile, R, Cerini and R. Ciampi et al., 2007. A rare case of brainstem encephalitis by Listeria monocytogenes with isolated mesencephalic localization. Case report and review. Diagn Microbiol. Infect. Dis., 58: 121-123.
    CrossRef  |  PubMed  |  Direct Link  |  
  24. Borgia, G. and I. Gentile, 2006. Treating chronic hepatitis B: Today and tomorrow. Curr. Med. Chem., 13: 2839-2855.
    CrossRef  |  PubMed  |  
  25. Gentile, I., C. Viola, L. Reynaud, F. Borrelli and R. Cerini et al., 2005. Hemolytic anemia during pegylated IFN-α2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. J. Interferon Cytokine Res., 25: 283-285.
    CrossRef  |  PubMed  |  Direct Link  |  
  26. Varriale, M., A. Salvio, F. Giannattasio, T. D'Errico and L. Montone et al., 2004. Intrahepatic cholestatic jaundice related to administration of ranitidine. A case report with histologic and ultramicroscopic study. Minerva Gastroenterol Dietol, 50: 339-343.
    PubMed  |  
  27. Tiseo, D., F. Borrelli, I. Gentile, G. Benassai, G. Quarto and G. Borgia, 2004. Cystic echinococcosis in humans: our clinic experience. Parassitologia, 46: 45-51.
    PubMed  |  
  28. Gentile, I., C. Viola, L. Reynaud, R. Cerini, S. Noce and R. Ciampi et al., 2003. Atypical visceral leishmaniasis: Two cases in HIV-negative patients. Giornale Italiano di Malattie Infettive, 9: 197-199.
  29. Borgia, G., L. Reynaud, I. Gentile, M. Piazza, 2003. HIV and Hepatitis C virus: Facts and controversies. Infection, 31: 232-240.
    CrossRef  |  PubMed  |  Direct Link  |  
  30. Borgia G., L. Reynaud, I. Gentile, F. Borrelli, R. Cerini, R. Ciampi and M. Piazza, 2003. Pernicious anemia during IFN-α treatment for chronic hepatitis C. J. Interferon Cytokine Res., 23: 11-12.
    CrossRef  |  PubMed  |  Direct Link  |  
  31. Fortunato, G., G. Castaldo, G. Oriani, R. Cerini and M. Intrieri et al., 2001. Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. Clinical Chemistry, 47: 1696-1700.
    PubMed  |  Direct Link  |  
  32. Borgia, G., L. Reynaud, I. Gentile, R. Cerini, R. Ciampi, M.D. Russo and M. Piazza, 2001. Myasthenia gravis during low-dose IFN-α therapy for chronic hepatitis C. J. Interferon Cytokine Res., 21: 469-470.
    CrossRef  |  PubMed  |  Direct Link  |  
  33. Borgia, G., L. Reynaud, R. Cerini, R. Ciampi and O. Schioppa et al., 2000. A case of Paracoccidioidomycosis: Experience with long-term Therapy Infection, 28: 119-120.
    CrossRef  |  PubMed  |  Direct Link  |